Q&A With Alan J. Thompson of University College London: Treatment of Progressive Multiple Sclerosis a High Priority in Medical Field

Video

Treatment of the relapsing form of multiple sclerosis has come a long way in recent years. The hope by researchers now is that treatment for progressive multiple sclerosis could be coming up sooner rather than later.

Treatment of the relapsing form of multiple sclerosis has come a long way in recent years. The hope by researchers now is that treatment for progressive multiple sclerosis could be coming up sooner rather than later.

Alan J. Thompson, MD, FRCP, from University College in London discussed how work to finding treatment has progressed. Part of that effort, he said, has been finding a uniformed definition for the condition. By identifying targets, he said it can help work move forward to helping the patients that need it.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.